155 related articles for article (PubMed ID: 12193046)
1. Peroxisome proliferator-activated receptor-gamma activators inhibit endothelin-1-related cardiac hypertrophy in rats.
Sakai S; Miyauchi T; Irukayama-Tomobe Y; Ogata T; Goto K; Yamaguchi I
Clin Sci (Lond); 2002 Aug; 103 Suppl 48():16S-20S. PubMed ID: 12193046
[TBL] [Abstract][Full Text] [Related]
2. Stimulation of peroxisome-proliferator-activated receptor alpha (PPAR alpha) attenuates cardiac fibrosis and endothelin-1 production in pressure-overloaded rat hearts.
Ogata T; Miyauchi T; Sakai S; Irukayama-Tomobe Y; Goto K; Yamaguchi I
Clin Sci (Lond); 2002 Aug; 103 Suppl 48():284S-288S. PubMed ID: 12193105
[TBL] [Abstract][Full Text] [Related]
3. Endothelin-1-induced cardiac hypertrophy is inhibited by activation of peroxisome proliferator-activated receptor-alpha partly via blockade of c-Jun NH2-terminal kinase pathway.
Irukayama-Tomobe Y; Miyauchi T; Sakai S; Kasuya Y; Ogata T; Takanashi M; Iemitsu M; Sudo T; Goto K; Yamaguchi I
Circulation; 2004 Feb; 109(7):904-10. PubMed ID: 14967736
[TBL] [Abstract][Full Text] [Related]
4. Peroxisome proliferator-activated receptor gamma activators inhibit cardiac hypertrophy in cardiac myocytes.
Yamamoto K; Ohki R; Lee RT; Ikeda U; Shimada K
Circulation; 2001 Oct; 104(14):1670-5. PubMed ID: 11581147
[TBL] [Abstract][Full Text] [Related]
5. Peroxisome proliferator-activated receptor-alpha and receptor-gamma activators prevent cardiac fibrosis in mineralocorticoid-dependent hypertension.
Iglarz M; Touyz RM; Viel EC; Paradis P; Amiri F; Diep QN; Schiffrin EL
Hypertension; 2003 Oct; 42(4):737-43. PubMed ID: 12860836
[TBL] [Abstract][Full Text] [Related]
6. Altered production of endothelin-1 in the hypertrophied rat heart.
Sakai S; Yorikane R; Miyauchi T; Sakurai T; Kasuya Y; Yamaguchi I; Sugishita Y; Goto K
J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S452-5. PubMed ID: 8587443
[TBL] [Abstract][Full Text] [Related]
7. Effect of pioglitazone on the expression of inflammatory cytokines in attenuating rat cardiomyocyte hypertrophy.
Ye P; Yang W; Wu SM; Sheng L
Methods Find Exp Clin Pharmacol; 2006 Dec; 28(10):691-6. PubMed ID: 17235413
[TBL] [Abstract][Full Text] [Related]
8. Pioglitazone, a specific ligand of the peroxisome proliferator-activated receptor gamma reduces gastric mucosal injury induced by ischaemia/ reperfusion in rat.
Konturek PC; Brzozowski T; Kania J; Kukharsky V; Bazela K; Kwiecien S; Harsch I; Konturek SJ; Hahn EG
Scand J Gastroenterol; 2003 May; 38(5):468-76. PubMed ID: 12795455
[TBL] [Abstract][Full Text] [Related]
9. Peroxisome proliferator-activated receptor gamma plays a critical role in inhibition of cardiac hypertrophy in vitro and in vivo.
Asakawa M; Takano H; Nagai T; Uozumi H; Hasegawa H; Kubota N; Saito T; Masuda Y; Kadowaki T; Komuro I
Circulation; 2002 Mar; 105(10):1240-6. PubMed ID: 11889020
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of acyl-CoA oxidase gene expression in heart of troglitazone-treated mice through a mechanism involving chicken ovalbumin upstream promoter transcription factor II.
Cabrero A; Jové M; Planavila A; Merlos M; Laguna JC; Vázquez-Carrera M
Mol Pharmacol; 2003 Sep; 64(3):764-72. PubMed ID: 12920214
[TBL] [Abstract][Full Text] [Related]
11. Activation of peroxisome proliferator-activated receptor-gamma contributes to the inhibitory effects of curcumin on rat hepatic stellate cell growth.
Xu J; Fu Y; Chen A
Am J Physiol Gastrointest Liver Physiol; 2003 Jul; 285(1):G20-30. PubMed ID: 12660143
[TBL] [Abstract][Full Text] [Related]
12. Induction mechanism of apoptosis by troglitazone through peroxisome proliferator-activated receptor-gamma in gastric carcinoma cells.
Yoshida K; Tanabe K; Fujii D; Oue N; Yasui W; Toge T
Anticancer Res; 2003; 23(1A):267-73. PubMed ID: 12680223
[TBL] [Abstract][Full Text] [Related]
13. Effect of pioglitazone, a peroxisome proliferator-activated receptor gamma agonist, on ischemia-reperfusion injury in rats.
Cao Z; Ye P; Long C; Chen K; Li X; Wang H
Pharmacology; 2007; 79(3):184-92. PubMed ID: 17356310
[TBL] [Abstract][Full Text] [Related]
14. Ameliorative effect of combination of fenofibrate and rosiglitazone in pressure overload-induced cardiac hypertrophy in rats.
Rose M; Balakumar P; Singh M
Pharmacology; 2007; 80(2-3):177-84. PubMed ID: 17570955
[TBL] [Abstract][Full Text] [Related]
15. Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) activation suppresses ischemic induction of Egr-1 and its inflammatory gene targets.
Okada M; Yan SF; Pinsky DJ
FASEB J; 2002 Dec; 16(14):1861-8. PubMed ID: 12468449
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator activated receptor (PPAR)alpha agonists inhibit hypertrophy of neonatal rat cardiac myocytes.
Liang F; Wang F; Zhang S; Gardner DG
Endocrinology; 2003 Sep; 144(9):4187-94. PubMed ID: 12933694
[TBL] [Abstract][Full Text] [Related]
17. Thiazolidinediones down-regulate plasminogen activator inhibitor type 1 expression in human vascular endothelial cells: A possible role for PPARgamma in endothelial function.
Kato K; Satoh H; Endo Y; Yamada D; Midorikawa S; Sato W; Mizuno K; Fujita T; Tsukamoto K; Watanabe T
Biochem Biophys Res Commun; 1999 May; 258(2):431-5. PubMed ID: 10329404
[TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferator-activated receptor ligands affect growth-related gene expression in human leukemic cells.
Laurora S; Pizzimenti S; Briatore F; Fraioli A; Maggio M; Reffo P; Ferretti C; Dianzani MU; Barrera G
J Pharmacol Exp Ther; 2003 Jun; 305(3):932-42. PubMed ID: 12649303
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of peroxisome proliferator-activated receptor activators on the mRNA levels of genes involved in lipid metabolism in primary human monocyte-derived macrophages.
Cabrero A; Cubero M; Llaverías G; Jové M; Planavila A; Alegret M; Sánchez R; Laguna JC; Carrera MV
Metabolism; 2003 May; 52(5):652-7. PubMed ID: 12759900
[TBL] [Abstract][Full Text] [Related]
20. Protective effects of preischemic treatment with pioglitazone, a peroxisome proliferator-activated receptor-gamma ligand, on lung ischemia-reperfusion injury in rats.
Ito K; Shimada J; Kato D; Toda S; Takagi T; Naito Y; Yoshikawa T; Kitamura N
Eur J Cardiothorac Surg; 2004 Apr; 25(4):530-6. PubMed ID: 15037267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]